Evotec expands compound management capability in the United States
News Apr 29, 2013
The facility, located in Branford Connecticut, is strategically positioned to support the strong presence of Evotec’s drug discovery collaborators along the East Coast of the United States. The new facility will be modern, cost effective and scalable for continued growth. The investment into industry leading technologies, specifically aimed at library management, and the access to incremental space will enable Evotec to better support the East Coast pharmaceutical and biopharmaceutical industry for the coming years. The facility will be fully operational early Q3 2013 and will complement the existing facility in South San Francisco which will continue to be fully operational and serve existing clients.
Scott Snyder, Executive Vice President Compound Management of Evotec, commented: “This is an important strategic expansion of our EVT Execute compound management offering which Evotec first acquired in South San Francisco in 2011. The significant investment will enable Evotec to better compete for East Coast compound management opportunities and continue to provide the very best services and solutions to our partners.“
BIA Separations appoints Pete Gagnon as Chief Scientific OfficerNews
Appointment will drive new product and applications development.READ MORE
Heart-on-a-chip Manufactured More Efficiently to Speed Up Drug TestingNews
Testing new clinical drugs' effect on heart tissue could become quicker and more straightforward, thanks to new research from Harvard University.
The study, sets out a new, faster method for manufacturing a 'heart-on-a-chip', which can be used to test the reaction of heart tissue to external stimuli.
PPD and Quotient Sciences Form Innovative Partnership to Accelerate Pediatric Drug DevelopmentNews
Will shorten timelines, reduce costs and simplify contracting process in pediatric programs.READ MORE